While patients with psoriasis -- a chronic skin condition -- respond well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease, according to a study.

Psoriasis, with its systemic inflammatory nature, high risk of cardiovascular disease, and frequent use of biologic drugs, could provide a valuable framework for studying residual inflammation.